Promethazine Hydrochloride Injection — FDA Drug Shortage

Current — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on Nov 21, 2023.

Shortage details

Status
Current
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-5525-3
Dosage Form
Injection
Presentation
Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)
Initial Posting
Nov 21, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.